Elizabeth is an industry veteran that brings over 20 years of dynamic cross functional leadership and advocacy development to our clients.  Her market access and advocacy background has been vetted by a career built within some of the top pharmaceutical and biotech companies to include Roche, Genentech and Lilly.   Elizabeth has experience bringing more than 30 breakthrough products to market across a variety of segments including rare disease and specialty.  Her passion for building pathways to optimize outcomes for patients and providers is deeply rooted in her commitment to deliver effective patient centric market strategies for companies both large and small.

She is a skilled communicator and experienced community facilitator for peer driven dialogues that place patients and caregivers at the forefront of shaping clinically meaningful research objectives and effective post launch market strategies.  Elizabeth has designed, recruited and facilitated a variety of engagement programs tailored to uncover and address the unique unmet needs of rare disease patient communities locally, nationally and even globally.

Elizabeth specializes in patient advocacy engagement, launch readiness and cultivating key stakeholder alignment to drive the results that matter most to the patients they serve.